Longer Survival
Revolution Medicines’ pancreatic cancer drug slashed risk of death in late-stage trial
Revolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.




